Expanding the frontiers of existing antiviral drugs : Possible effects of HIV-1 protease inhibitors against SARS and avian influenza
Identifieur interne : 005172 ( Main/Merge ); précédent : 005171; suivant : 005173Expanding the frontiers of existing antiviral drugs : Possible effects of HIV-1 protease inhibitors against SARS and avian influenza
Auteurs : Andrea Savarino [Italie]Source :
- Journal of clinical virology [ 1386-6532 ] ; 2005.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
When unexpected diseases such as the severe acute respiratory syndrome (SARS) and avian influenza become a serious threat to public health, an immediate response is imperative. This should take into consideration existing licensed antiviral drugs against other viral diseases already known to be safe for use in humans. In this report, evidence is presented that HIV-1 protease inhibitors (Pis) currently used in anti-HIV-1 therapies might exert some effects on SARS and perhaps, on avian influenza. Evidence for the potential benefits of PIs against the SARS coronavirus (SARS-CoV) is provided by empirical clinical studies, in vivo viral inhibition assays and computational simulations of the docking of these compounds to the active site of the main SARS-CoV protease. As suggested by in silico docking of these molecules to a theoretical model of a subunit of type A influenza virus RNA-dependent RNA polymerase, there also exists a remote possibility that these PIs may have an effect on avian influenza viruses. Although this evidence is still far from being definitive, the results so far obtained suggest that PIs should be seriously taken into consideration for further testing as potential therapeutic agents for SARS and avian influenza.
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000585
- to stream PascalFrancis, to step Curation: 000405
- to stream PascalFrancis, to step Checkpoint: 000652
Links to Exploration step
Pascal:05-0475002Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Expanding the frontiers of existing antiviral drugs : Possible effects of HIV-1 protease inhibitors against SARS and avian influenza</title><author><name sortKey="Savarino, Andrea" sort="Savarino, Andrea" uniqKey="Savarino A" first="Andrea" last="Savarino">Andrea Savarino</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Viral Immunology, Department of Infectious Diseases, Università Cattolica del Sacro Cuore, Largo Agostino Gemelli 8</s1><s2>00168 Rome</s2><s3>ITA</s3><sZ>1 aut.</sZ></inist:fA14><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">05-0475002</idno><date when="2005">2005</date><idno type="stanalyst">PASCAL 05-0475002 INIST</idno><idno type="RBID">Pascal:05-0475002</idno><idno type="wicri:Area/PascalFrancis/Corpus">000585</idno><idno type="wicri:Area/PascalFrancis/Curation">000405</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000652</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000652</idno><idno type="wicri:doubleKey">1386-6532:2005:Savarino A:expanding:the:frontiers</idno><idno type="wicri:Area/Main/Merge">005172</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Expanding the frontiers of existing antiviral drugs : Possible effects of HIV-1 protease inhibitors against SARS and avian influenza</title><author><name sortKey="Savarino, Andrea" sort="Savarino, Andrea" uniqKey="Savarino A" first="Andrea" last="Savarino">Andrea Savarino</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Laboratory of Viral Immunology, Department of Infectious Diseases, Università Cattolica del Sacro Cuore, Largo Agostino Gemelli 8</s1><s2>00168 Rome</s2><s3>ITA</s3><sZ>1 aut.</sZ></inist:fA14><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author></analytic><series><title level="j" type="main">Journal of clinical virology</title><title level="j" type="abbreviated">J. clin. virol.</title><idno type="ISSN">1386-6532</idno><imprint><date when="2005">2005</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Journal of clinical virology</title><title level="j" type="abbreviated">J. clin. virol.</title><idno type="ISSN">1386-6532</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiretroviral agent</term><term>Antiviral</term><term>Avian influenza</term><term>Coronavirus</term><term>HIV-1 virus</term><term>Influenza A</term><term>Microbiology</term><term>Peptidases</term><term>RNA-directed RNA polymerase</term><term>Severe acute respiratory syndrome</term><term>Virology</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Virus HIV1</term><term>Coronavirus</term><term>Antiviral</term><term>Peptidases</term><term>Antirétroviral</term><term>RNA-directed RNA polymerase</term><term>Microbiologie</term><term>Virologie</term><term>Syndrome respiratoire aigu sévère</term><term>Grippe A</term><term>Grippe aviaire</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">When unexpected diseases such as the severe acute respiratory syndrome (SARS) and avian influenza become a serious threat to public health, an immediate response is imperative. This should take into consideration existing licensed antiviral drugs against other viral diseases already known to be safe for use in humans. In this report, evidence is presented that HIV-1 protease inhibitors (Pis) currently used in anti-HIV-1 therapies might exert some effects on SARS and perhaps, on avian influenza. Evidence for the potential benefits of PIs against the SARS coronavirus (SARS-CoV) is provided by empirical clinical studies, in vivo viral inhibition assays and computational simulations of the docking of these compounds to the active site of the main SARS-CoV protease. As suggested by in silico docking of these molecules to a theoretical model of a subunit of type A influenza virus RNA-dependent RNA polymerase, there also exists a remote possibility that these PIs may have an effect on avian influenza viruses. Although this evidence is still far from being definitive, the results so far obtained suggest that PIs should be seriously taken into consideration for further testing as potential therapeutic agents for SARS and avian influenza.</div></front></TEI><affiliations><list><country><li>Italie</li></country><region><li>Latium</li></region><settlement><li>Rome</li></settlement></list><tree><country name="Italie"><region name="Latium"><name sortKey="Savarino, Andrea" sort="Savarino, Andrea" uniqKey="Savarino A" first="Andrea" last="Savarino">Andrea Savarino</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005172 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 005172 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Merge
|type= RBID
|clé= Pascal:05-0475002
|texte= Expanding the frontiers of existing antiviral drugs : Possible effects of HIV-1 protease inhibitors against SARS and avian influenza
}}
| This area was generated with Dilib version V0.6.33. |  |